Lynx1 Capital Management LP

Korro Bio, Inc. ยท 10% Owner

Lynx1 Capital Management LP is listed in public filings as 10 percent owner. This Lynx1 Capital Management LP insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Korro Bio, Inc. (KRRO), TScan Therapeutics, Inc. (TCRX), Cullinan Therapeutics, Inc. (CGEM), and Passage Bio, Inc. (PASG). Investors use Lynx1 Capital Management LP's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Korro Bio, Inc.KRRO$16M1.5M sharesBuyMar 31, 2026$5.5K520 shares$10.60--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
TScan Therapeutics, Inc.TCRX$7.2M8M sharesBuyDec 23, 2025$5.6K6.2k shares$0.8989--
TScan Therapeutics, Inc.TCRX$7.2M8M sharesBuyDec 22, 2025$68.0K75.5k shares$0.90--
TScan Therapeutics, Inc.TCRX$7.1M7.9M sharesBuyDec 19, 2025$72.0K80.1k shares$0.8989--
Cullinan Therapeutics, Inc.CGEM$75M9M sharesBuyOct 28, 2025$1.4M165.7k shares$8.40--
Cullinan Therapeutics, Inc.CGEM$69M8.8M sharesBuyOct 17, 2025$252.6K32.2k shares$7.84--
Cullinan Therapeutics, Inc.CGEM$78M8.8M sharesBuyOct 16, 2025$1.3M150k shares$8.86--
Cullinan Therapeutics, Inc.CGEM$68M8.6M sharesBuyOct 15, 2025$409.0K51.5k shares$7.94--
Cullinan Therapeutics, Inc.CGEM$65M8.6M sharesBuyOct 14, 2025$114.0K15k shares$7.59--
Cullinan Therapeutics, Inc.CGEM$63M8.5M sharesBuyOct 10, 2025$2.0M277.3k shares$7.36--
Cullinan Therapeutics, Inc.CGEM$55M8.3M sharesBuyOct 9, 2025$4.2M626k shares$6.70--
Cullinan Therapeutics, Inc.CGEM$49M7.6M sharesBuyOct 8, 2025$3.6M556.3k shares$6.46--
Passage Bio, Inc.PASG$4.4M623.7k sharesBuySep 15, 2025$83.2K11.9k shares$6.99--
Passage Bio, Inc.PASG$4.3M611.8k sharesBuySep 12, 2025$138.3K19.8k shares$6.99--
Passage Bio, Inc.PASG$4.1M592k sharesBuySep 11, 2025$2.3K325 shares$6.96--
Passage Bio, Inc.PASG$3.4M591.7k sharesBuyJul 24, 2025$379.5K66.4k shares$5.71--
Passage Bio, Inc.PASG$3.0M525.3k sharesBuyJul 23, 2025$283.0K49.3k shares$5.74--
Passage Bio, Inc.PASG$2.6M476k sharesBuyJul 22, 2025$71.3K13.1k shares$5.44--
TScan Therapeutics, Inc.TCRX$9.5M7.9M sharesBuyMay 20, 2025$1.4M1.2M shares$1.20--
TScan Therapeutics, Inc.TCRX$8.1M6.7M sharesBuyMay 19, 2025$1.7M1.4M shares$1.20--
Passage Bio, Inc.PASG$6.0M9.3M sharesBuyDec 27, 2024$241.0K373.6k shares$0.6451--
TScan Therapeutics, Inc.TCRX$7507.5M sharesBuyDec 26, 2024$7507.5M shares$0.0001--
TScan Therapeutics, Inc.TCRX$16M5.4M sharesBuyDec 13, 2024$290.1K100k shares$2.90--
TScan Therapeutics, Inc.TCRX$16M5.3M sharesBuyDec 12, 2024$95.6K31.8k shares$3.01--
Passage Bio, Inc.PASG$6.0M8.9M sharesBuyNov 27, 2024$19.7K29.3k shares$0.6711--
Passage Bio, Inc.PASG$6.3M8.9M sharesBuyNov 26, 2024$118.2K167.1k shares$0.7075--
Passage Bio, Inc.PASG$4.9M8.7M sharesBuyNov 25, 2024$146.7K260k shares$0.5641--
TScan Therapeutics, Inc.TCRX$23M5.2M sharesBuyNov 15, 2024$4.1K947 shares$4.34--